Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01808937 · ClinicalTrials.gov registry record
Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
A clinical trial of Morphea and Scleroderma, Circumscribed, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- 500
- Enrollment target
- 1
- Study location
NCT01808937 is a study of Morphea and Scleroderma, Circumscribed that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 500 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01808937, a study of Morphea and Scleroderma, Circumscribed, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 1
- Study location
Study Summary
The Morphea in Adults and Children (MAC) cohort is the first registry for both children and adults with morphea (also known as localized scleroderma) in the country. The purpose of the registry is to learn more about morphea, specifically: * How morphea behaves over time * How frequently specific problems occur along with morphea (for example, arthritis) * Whether morphea has an autoimmune background
Conditions Studied
Interventions
- OTHER Morphea
Study Locations (1)
Texas
- UT Southwestern Medical Center - Department of Dermatology - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2007-05 |
| Est. Completion | 2028-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01808937
The ClinicalTrials.gov registry entry for NCT01808937 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Morphea appearing as the primary indexed condition, and to 1 intervention - of which Morphea is the first listed.
NCT01808937 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01808937 about?
NCT01808937 is a clinical study titled "Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository". The Morphea in Adults and Children (MAC) cohort is the first registry for both children and adults with morphea (also known as localized scleroderma) in the country. The purpose of the registry is to learn more about morphea, specifically: * How morphea behaves over time * How frequently specific p...
What is the current status of trial NCT01808937?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2007-05. Estimated completion is 2028-01.
What conditions does trial NCT01808937 study?
This clinical trial studies the following conditions: Morphea, Scleroderma, Circumscribed, Scleroderma, Localized, Frontal Linear Scleroderma en Coup de Sabre, Scleroderma, Linear.
What interventions are being tested in trial NCT01808937?
The interventions under investigation include: Morphea (OTHER).
Who is sponsoring clinical trial NCT01808937?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01808937 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Morphea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.